What are the risks and benefits of the LIFT (Ligation of Intersphincteric Fistula Tract) procedure compared to the FLAP (Fistula Repair with Anal Flap) procedure for a patient concerned about the mental toll of surgery and considering alternative options due to the low success rate of LIFT?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

LIFT vs. Advancement Flap for Complex Perianal Fistulas

Direct Recommendation

For patients concerned about mental toll and surgical outcomes, advancement flap (FLAP) should be the preferred initial approach over LIFT, as both procedures achieve similar healing rates (61% vs. 53% in Crohn's disease patients), but LIFT's fragility and higher true recurrence rates (21% vs. 7.8%) create ongoing psychological burden despite its lower incontinence risk. 1

Understanding the Real Success Rates

Your concerns about LIFT are validated by the evidence:

  • Initial meta-analyses reported misleadingly optimistic results with 69-77% success rates in general populations, but these included heterogeneous studies with varying follow-up periods and outcome definitions 1

  • In Crohn's disease specifically, LIFT achieves only 53% success compared to 61% for advancement flaps—essentially equivalent outcomes 1

  • The "1.6% recurrence rate" widely cited is likely severe underreporting, as more recent prospective data reveals 21% recurrence rates with adequate follow-up 1, 2

  • Complex and recurrent fistulas have even worse outcomes, with success rates dropping to 50% for complex fistulas and only 33% for recurrent fistulas 3

The Mental Toll Factor: Why LIFT May Be Worse

The psychological burden you describe stems from LIFT's specific failure pattern:

  • Median time to failure is approximately 4 months after an initially successful closure, creating false hope followed by disappointment 2

  • The repair remains fragile indefinitely—only patients with completely fibrotic tracts on MRI avoid reinterventions during long-term follow-up 1

  • After LIFT failure, 50% of salvage procedures still fail, requiring ongoing treatment cycles with setons, repeat flaps, or fistulotomy 4

  • Failed LIFT converts 75% of fistulas back to transsphincteric and 25% to intersphincteric, requiring the same complex management you started with 4

Advancement Flap: The More Definitive Option

Despite its drawbacks, advancement flap offers advantages for psychological well-being:

  • Success rates range from 47-90% with recurrence rates of only 15-20%—when it works, it's more durable 1

  • Outcomes improve dramatically with optimization: 100% success rate in diverted patients and higher healing rates when performed after anti-TNF therapy and seton drainage 1

  • The higher incontinence risk (7.8% vs. 1.6%) is the main tradeoff, but 43% of flap patients actually experience improved continence postoperatively 1

Addressing Your Specific Concerns

Why some surgeons avoid LIFT:

  • Inadequate patient selection is the primary reason for failure—branching fistulas, active proctitis, and poorly epithelialized tracts predict poor outcomes 2

  • Smoking increases failure risk 3.2-fold, and active proctitis doubles failure risk (HR 2.0) 1, 5

  • The narrow surgical field makes the procedure technically demanding with limited visualization 6

The fibrin glue and plug comparison you mentioned is accurate:

  • Fibrin glue achieves only 38-45% success and is explicitly not recommended by ECCO guidelines 1

  • Fistula plugs show 30-33% closure rates with 17% complication rates—both are inferior to LIFT or flaps 2

Clinical Algorithm for Decision-Making

Choose advancement flap over LIFT when:

  • Patient prioritizes definitive closure over continence preservation (can tolerate 7.8% incontinence risk) 1
  • Patient has undergone optimization with anti-TNF therapy and seton drainage 1
  • Patient can undergo temporary fecal diversion if needed (achieves 100% success) 1
  • Patient's psychological state cannot tolerate the 21% recurrence risk and fragile repair of LIFT 1, 2

Consider LIFT only when:

  • Patient has single, non-branching fistula with well-epithelialized tract 1, 2
  • Patient is non-smoker with no active proctitis 1, 5
  • Patient prioritizes continence preservation above all else (1.6% vs. 7.8% incontinence) 1
  • Patient accepts 53% success rate and understands need for MRI confirmation of fibrotic tract 1

Avoid both procedures when:

  • Active proctitis is present—optimize medical therapy first 2
  • Patient is actively smoking—must quit before surgery 5
  • Multiple branching tracts or poorly defined anatomy exists 2

Alternative Strategy for Mental Health Preservation

Long-term loose seton with medical therapy may be the most psychologically protective option for patients who cannot tolerate repeated surgical failures:

  • Avoids the cycle of hope and disappointment from failed definitive repairs 5
  • Combined with anti-TNF therapy, provides acceptable quality of life 1
  • Preserves all future surgical options without creating additional scarring 5
  • Recommended by multiple societies for patients unable to maintain adequate hygiene or with severe limitations 2, 5

Critical Pitfall to Avoid

Do not declare LIFT success based on clinical healing alone—radiological confirmation with MRI showing complete tract obliteration and fibrosis is essential to predict durability 1, 2. Clinical closure without radiological healing predicts eventual recurrence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ligation of Intersphincteric Fistula Tract (LIFT) for Complex Perianal Fistulas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

What happens after a failed LIFT for anal fistula?

American journal of surgery, 2017

Guideline

LIFT Procedure Failure and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the initial treatment for a complex fistula in ano?
What are the management options for a patient with a history of receptive anal sex and a low transsphincteric fistula who has undergone a failed LIFT (Ligation of the Intersphincteric Fistula Tract) procedure?
Is fibrotic tissue, although less flexible, stronger against bacterial infection due to its mechanical strength in a patient with a history of failed LIFT (Ligation of the Intersphincteric Fistula Tract) procedure and complete fibroid tract, as well as a history of anal fistula?
Can LIFT (Ligation of Intersphincteric Fistula Tract) procedures fail years later in older adult patients with low transphincteric fistulas?
Can pelvic floor therapy help a patient with a history of failed LIFT (Ligation of Intersphincteric Fistula Tract) procedure and no fecal or flatus incontinence, but experiencing a breezier feeling in the fistulotomy site with occasional small amounts of air leakage?
What is the best approach to manage ongoing pain in a 45-year-old female with a history of prolapse bladder, appendicitis, claw toes, recent umbilical hernia surgery with complications, and visceral pseudo-aneurysm of the Pancreaticoduodental (PDA) artery repair?
What oral antibiotics are recommended to treat Methicillin-Sensitive Staphylococcus aureus (MSSA) pneumonia?
What is the first-line treatment for bacterial conjunctivitis in a patient with a penicillin allergy?
What are the suggested tests for a patient with recent left orthopedic surgery to the hip and thigh, who reports bilateral numbness above both knees, but has normal pedal pulses (2+), can move their feet, and no other symptoms such as numbness, tingling, or discoloration?
What is the appropriate diagnosis and treatment for an elderly female patient presenting with dark urine, abdominal pain, and a cold sensation, considering her potential compromised immune system and possible underlying conditions such as urinary tract infection (UTI), kidney stones, or sepsis?
What ethical principle is most relevant when a patient with a specific medical condition is invited to participate in a clinical trial for a new drug and is concerned about being placed in the placebo group, but is reassured by the provider?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.